Document is current
Any future updates will be listed below
-
Authors
Driendl, Sarah
Stadler, Stefan
Baumert, Mathias
Stark, Klaus J.
Heid, Iris M.
Pec, Jan
Zeman, Florian
Preiss, Adrian
Böger, Carsten A.
Bergler, Tobias
Arzt, Michael
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00010498 at German Clinical Trials RegisterDocuments that mention this clinical trial
Nocturnal hypoxemic burden is associated with worsening prognosis of chronic kidney disease in patients with type 2 diabetes
https://doi.org/10.1186/s12933-025-02918-y
-
Funding
Funding for this research was provided by:
Universitätsklinikum Regensburg
- License Information
-
More Information
Article History
Received: 17 July 2025
Accepted: 22 August 2025
First Online: 31 August 2025
Declarations
:
: The DIACORE study and its protocol have been approved by the University of Regensburg Ethics Committee (vote 06-139) and were in accordance with the Declaration of Helsinki. Participation in the DIACORE study was based on the patient`s written consent. The reporting adhered to the STROBE checklist for observational studies. The study is registered with the German Clinical Trials Register (DRKS00010498).
: Not applicable.
: MA has received grant support from ResMed, the ResMed Foundation, Philips Respironics and the German Research Foundation (DFG; AR495/4-0), German Federal Ministry of Education and Research (BMBF, project number: 01ZZ2324C), the Else Kroener-Fresenius Foundation (EKFS, project number: 2018_A159), and lecture and consulting fees from ResMed, Philips Respironics, Zoll, Lilly and Inspire Medical Systems. SD reports a grant from the German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD). SS, JP, FZ, KJS, IMH, AP, CAB, and MB have nothing to disclose.
